Familial Primary Pulmonary Hypertension
"Familial Primary Pulmonary Hypertension" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.
Descriptor ID |
D065627
|
MeSH Number(s) |
C08.381.423.847
|
Concept/Terms |
Idiopathic Pulmonary Arterial Hypertension- Idiopathic Pulmonary Arterial Hypertension
- Primary Pulmonary Hypertension
- Hypertension, Primary Pulmonary
- Hypertensions, Primary Pulmonary
- Primary Pulmonary Hypertensions
- Pulmonary Hypertension, Primary
- Pulmonary Hypertensions, Primary
- Pulmonary Hypertension, Primary, 1
- Idiopathic Pulmonary Hypertension
- Hypertension, Idiopathic Pulmonary
- Hypertensions, Idiopathic Pulmonary
- Idiopathic Pulmonary Hypertensions
- Pulmonary Hypertension, Idiopathic
- Pulmonary Hypertensions, Idiopathic
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia- Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia
- Pph1 With Hht
- Hht, Pph1 With
- Hhts, Pph1 With
- Pph1 With Hhts
- With Hht, Pph1
- With Hhts, Pph1
|
Below are MeSH descriptors whose meaning is more general than "Familial Primary Pulmonary Hypertension".
Below are MeSH descriptors whose meaning is more specific than "Familial Primary Pulmonary Hypertension".
This graph shows the total number of publications written about "Familial Primary Pulmonary Hypertension" by people in this website by year, and whether "Familial Primary Pulmonary Hypertension" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 3 | 3 | 2012 | 0 | 3 | 3 | 2013 | 0 | 2 | 2 | 2014 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Familial Primary Pulmonary Hypertension" by people in Profiles.
-
West JD, Austin ED, Gaskill C, Marriott S, Baskir R, Bilousova G, Jean JC, Hemnes AR, Menon S, Bloodworth NC, Fessel JP, Kropski JA, Irwin D, Ware LB, Wheeler L, Hong CC, Meyrick B, Loyd JE, Bowman AB, Ess KC, Klemm DJ, Young PP, Merryman WD, Kotton D, Majka SM. Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension. Am J Physiol Cell Physiol. 2014 Sep 01; 307(5):C415-30.
-
Hemnes AR, Brittain EL, Trammell AW, Fessel JP, Austin ED, Penner N, Maynard KB, Gleaves L, Talati M, Absi T, Disalvo T, West J. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):325-34.
-
Brittain E, Penner NL, West J, Hemnes A. Echocardiographic assessment of the right heart in mice. J Vis Exp. 2013 Nov 27; (81).
-
Fessel JP, Flynn CR, Robinson LJ, Penner NL, Gladson S, Kang CJ, Wasserman DH, Hemnes AR, West JD. Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. Am J Respir Cell Mol Biol. 2013 Nov; 49(5):778-87.
-
Cogan J, Austin E, Hedges L, Womack B, West J, Loyd J, Hamid R. Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance. Circulation. 2012 Oct 09; 126(15):1907-16.
-
Larkin EK, Newman JH, Austin ED, Hemnes AR, Wheeler L, Robbins IM, West JD, Phillips JA, Hamid R, Loyd JE. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012 Nov 01; 186(9):892-6.
-
Flynn C, Zheng S, Yan L, Hedges L, Womack B, Fessel J, Cogan J, Austin E, Loyd J, West J, Zhao Z, Hamid R. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance. Am J Respir Cell Mol Biol. 2012 Jul; 47(1):20-7.
-
Johnson JA, Hemnes AR, Perrien DS, Schuster M, Robinson LJ, Gladson S, Loibner H, Bai S, Blackwell TR, Tada Y, Harral JW, Talati M, Lane KB, Fagan KA, West J. Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2012 Mar 01; 302(5):L474-84.
-
Majka S, Hagen M, Blackwell T, Harral J, Johnson JA, Gendron R, Paradis H, Crona D, Loyd JE, Nozik-Grayck E, Stenmark KR, West J. Physiologic and molecular consequences of endothelial Bmpr2 mutation. Respir Res. 2011 Jun 22; 12:84.
-
Jun D, Garat C, West J, Thorn N, Chow K, Cleaver T, Sullivan T, Torchia EC, Childs C, Shade T, Tadjali M, Lara A, Nozik-Grayck E, Malkoski S, Sorrentino B, Meyrick B, Klemm D, Rojas M, Wagner DH, Majka SM. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells. 2011 Apr; 29(4):725-35.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|